Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-037555
Filing Date
2023-08-03
Accepted
2023-08-03 06:45:43
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q krtx-20230630.htm   iXBRL 10-Q 2586638
2 EX-31.1 krtx-ex31_1.htm EX-31.1 17609
3 EX-31.2 krtx-ex31_2.htm EX-31.2 17767
4 EX-32.1 krtx-ex32_1.htm EX-32.1 17882
  Complete submission text file 0000950170-23-037555.txt   9069291

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krtx-20230630_pre.xml EX-101.PRE 317065
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krtx-20230630.xsd EX-101.SCH 56404
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krtx-20230630_lab.xml EX-101.LAB 433814
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krtx-20230630_cal.xml EX-101.CAL 54530
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krtx-20230630_def.xml EX-101.DEF 168882
55 EXTRACTED XBRL INSTANCE DOCUMENT krtx-20230630_htm.xml XML 1755889
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38958 | Film No.: 231137952
SIC: 2834 Pharmaceutical Preparations